Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity (original) (raw)

• Jones, P. A. & Baylin, S. B. The epigenomics of cancer. Cell 128, 683–692 (2007).
  Article CAS Google Scholar
• Baylin, S. B. et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10, 687–692 (2001).
  Article CAS Google Scholar
• Bird, A. P. & Wolffe, A. P. Methylation-induced repression—belts, braces, and chromatin. Cell 99, 451–454 (1999).
  Article CAS Google Scholar
• Jones, P. A. & Laird, P. W. Cancer epigenetics comes of age. Nature Genet. 21, 163–167 (1999).
  Article CAS Google Scholar
• Lund, A. H. & van Lohuizen, M. Epigenetics and cancer. Genes Dev. 18, 2315–2335 (2004).
  Article CAS Google Scholar
• Bracken, A. P., Dietrich, N., Pasini, D., Hansen, K. H. & Helin, K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 20, 1123–1136 (2006).
  Article CAS Google Scholar
• Sparmann, A. & van Lohuizen, M. Polycomb silencers control cell fate, development and cancer. Nature Rev. Cancer 6, 846–856 (2006).
  Article CAS Google Scholar
• Schlesinger, Y. et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nature Genet. 39, 232–236 (2007).
  Article CAS Google Scholar
• Widschwendter, M. et al. Epigenetic stem cell signature in cancer. Nature Genet. 39, 157–158 (2007).
  Article CAS Google Scholar
• Santos-Reboucas, C. B. & Pimentel, M. M. Implication of abnormal epigenetic patterns for human diseases. Eur. J. Hum. Genet. 15, 10–17 (2007).
  Article CAS Google Scholar
• Ohm, J. E. et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nature Genet. 39, 237–242 (2007).
  Article CAS Google Scholar
• Ting, A. H., McGarvey, K. M. & Baylin, S. B. The cancer epigenome—components and functional correlates. Genes Dev. 20, 3215–3231 (2006).
  Article CAS Google Scholar
• Frigola, J. et al. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nature Genet. 38, 540–549 (2006).
  Article CAS Google Scholar
• Smith, J. S. & Costello, J. F. A broad band of silence. Nature Genet. 38, 504–506 (2006).
  Article CAS Google Scholar
• Nie, Y. et al. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 22, 1615–1623 (2001).
  Article CAS Google Scholar
• van Noesel, M. M. et al. Clustering of hypermethylated genes in neuroblastoma. Genes, Chrom. Cancer 38, 226–233 (2003).
  Article CAS Google Scholar
• Palmisano, W. A. et al. Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers. Cancer Res. 63, 4620–4625 (2003).
  CAS PubMed Google Scholar
• Novak, P. et al. Epigenetic inactivation of the HOXA gene cluster in breast cancer. Cancer Res. 66, 10664–10670 (2006).
  Article CAS Google Scholar
• Stransky, N. et al. Regional copy number-independent deregulation of transcription in cancer. Nature Genet. 38, 1386–1396 (2006).
  Article CAS Google Scholar
• Hitchins, M. P. et al. Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer. Cancer Res. 67, 9107–9116 (2007).
  Article CAS Google Scholar
• Novak, P. et al. Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res. 68, 8616–8625 (2008).
  Article CAS Google Scholar
• Kim, H. et al. The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Res. 65, 8118–8124 (2005).
  Article CAS Google Scholar
• Dhanasekaran, S. M. et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822–826 (2001).
  Article CAS Google Scholar
• Dhanasekaran, S. M. et al. Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty. FASEB J. 19, 243–245 (2005).
  Article CAS Google Scholar
• Lapointe, J. et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl Acad. Sci. USA 101, 811–816 (2004).
  Article CAS Google Scholar
• Luo, J. et al. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res. 61, 4683–4688 (2001).
  CAS PubMed Google Scholar
• Singh, D. et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1, 203–209 (2002).
  Article CAS Google Scholar
• Tomlins, S. A. et al. Integrative molecular concept modeling of prostate cancer progression. Nature Genet. 39, 41–51 (2007).
  Article CAS Google Scholar
• Vanaja, D. K., Cheville, J. C., Iturria, S. J. & Young, C. Y. Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Res. 63, 3877–3882 (2003).
  CAS PubMed Google Scholar
• Welsh, J. B. et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974–5978 (2001).
  CAS PubMed Google Scholar
• Yu, Y. P. et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol. 22, 2790–2799 (2004).
  Article CAS Google Scholar
• Feltus, F. A., Lee, E. K., Costello, J. F., Plass, C. & Vertino, P. M. DNA motifs associated with aberrant CpG island methylation. Genomics 87, 572–579 (2006).
  Article CAS Google Scholar
• Guelen, L. et al. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 453, 948–951 (2008).
  Article CAS Google Scholar
• Engstrom, P. G., Fredman, D. & Lenhard, B. Ancora: a web resource for exploring highly conserved noncoding elements and their association with developmental regulatory genes. Genome Biol. 9, R34 (2008).
  Article Google Scholar
• Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature Genet. 40, 499–507 (2008).
  Article CAS Google Scholar
• Gupta, P. B., Chaffer, C. L. & Weinberg, R. A. Cancer stem cells: mirage or reality? Nature Med. 15, 1010–1012 (2009).
  Article CAS Google Scholar
• Cher, M. L. et al. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res. 56, 3091–3102 (1996).
  CAS PubMed Google Scholar
• Dumur, C. I. et al. Genome-wide detection of LOH in prostate cancer using human SNP microarray technology. Genomics 81, 260–269 (2003).
  Article CAS Google Scholar
• Latil, A., Cussenot, O., Fournier, G., Baron, J. C. & Lidereau, R. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. Clin. Cancer Res. 1, 1385–1389 (1995).
  CAS PubMed Google Scholar
• Henrique, R. et al. High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients. Clin. Cancer Res. 13, 6122–6129 (2007).
  Article CAS Google Scholar
• Kohonen-Corish, M. R. et al. Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer. Oncogene 26, 4435–4441 (2007).
  Article CAS Google Scholar
• Guan, M., Zhou, X., Soulitzis, N., Spandidos, D. A. & Popescu, N. C. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clin. Cancer Res. 12, 1412–1419 (2006).
  Article CAS Google Scholar
• Chene, L. et al. Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene. Int. J. Cancer 111, 798–804 (2004).
  Article CAS Google Scholar
• Bachmann, N. et al. Expression changes of CAV1 and EZH2, located on 7q31 approximately q36, are rarely related to genomic alterations in primary prostate carcinoma. Cancer Genet. Cytogenet. 182, 103–110 (2008).
  Article CAS Google Scholar
• Tatarelli, C., Linnenbach, A., Mimori, K. & Croce, C. M. Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2. Genomics 68, 1–12 (2000).
  Article CAS Google Scholar
• Tobias, E. S., Hurlstone, A. F., MacKenzie, E., McFarlane, R. & Black, D. M. The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Oncogene 20, 2844–2853 (2001).
  Article CAS Google Scholar
• Friedman, J. M. et al. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res. 69, 2623–2629 (2009).
  Article CAS Google Scholar
• Varambally, S. et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322, 1695–1699 (2008).
  Article CAS Google Scholar
• Fabbri, M. et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA 104, 15805–15810 (2007).
  Article CAS Google Scholar
• Gandellini, P. et al. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res. 69, 2287–2295 (2009).
  Article CAS Google Scholar
• Ke, X. S. et al. Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLoS ONE 4, e4687 (2009).
  Article Google Scholar
• O'Hagan, H. M., Mohammad, H. P. & Baylin, S. B. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet. 4, e1000155 (2008).
  Article Google Scholar
• Hong, Z. et al. A polycomb group protein, PHF1, is involved in the response to DNA double-strand breaks in human cell. Nucleic Acids Res. 36, 2939–2947 (2008).
  Article CAS Google Scholar
• Schotta, G. et al. A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev. 22, 2048–2061 (2008).
  Article CAS Google Scholar
• Gal-Yam, E. N. et al. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc. Natl Acad. Sci. USA 105, 12979–12984 (2008).
  Article Google Scholar
• Barski, A. et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823–837 (2007).
  Article CAS Google Scholar
• Wen, B., Wu, H., Shinkai, Y., Irizarry, R. A. & Feinberg, A. P. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nature Genet. 41, 246–250 (2009).
  Article CAS Google Scholar
• Pauler, F. M. et al. H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome. Genome Res. 19, 221–233 (2009).
  Article CAS Google Scholar
• Pajerowski, J. D., Dahl, K. N., Zhong, F. L., Sammak, P. J. & Discher, D. E. Physical plasticity of the nucleus in stem cell differentiation. Proc. Natl Acad. Sci. USA 104, 15619–15624 (2007).
  Article CAS Google Scholar
• Spivakov, M. & Fisher, A. G. Epigenetic signatures of stem-cell identity. Nature Rev. Genet. 8, 263–271 (2007).
  Article CAS Google Scholar
• Feinberg, A. P. Phenotypic plasticity and the epigenetics of human disease. Nature 447, 433–440 (2007).
  Article CAS Google Scholar
• Wiblin, A. E., Cui, W., Clark, A. J. & Bickmore, W. A. Distinctive nuclear organisation of centromeres and regions involved in pluripotency in human embryonic stem cells. J. Cell Sci. 118, 3861–3868 (2005).
  Article CAS Google Scholar
• Liu, P. et al. Sex-determining region Y Box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res. 66, 4011–4019 (2006).
  Article CAS Google Scholar
• Varambally, S. et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8, 393–406 (2005).
  Article CAS Google Scholar
• Song, J. Z., Stirzaker, C., Harrison, J., Melki, J. R. & Clark, S. J. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene 21, 1048–1061 (2002).
  Article CAS Google Scholar
• Frigola, J. et al. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nature Genet. 38, 540–549 (2006).
  Article CAS Google Scholar
• Johnson, W. E. et al. Model-based analysis of tiling-arrays for ChIP-chip. Proc. Natl Acad. Sci. USA 103, 12457–12462 (2006).
  Article CAS Google Scholar
• Liu, P. et al. Sex-determining region Y Box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res. 66, 4011–4019 (2006).
  Article CAS Google Scholar
• Clark, S. J., Harrison, J., Paul, C. L. & Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22, 2990–2997 (1994).
  Article CAS Google Scholar
• Coolen, M. W., Statham, A. L., Gardiner-Garden, M. & Clark, S. J. Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res. 35, e119 (2007).
  Article Google Scholar
• Varambally, S. et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8, 393–406 (2005).
  Article CAS Google Scholar
• Khalili, A. et al. γ-Normal-γ mixture model for dtecting differentially methylated loci in three breast cancer cell lines. Cancer Informatics 3, 43–54 (2007).
  Article Google Scholar